arrow
A

A. Craig Lockhart

washington university (wustl)
H指数:43
被引数:9,114

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

德法替尼、派姆单抗和吉西他滨治疗晚期难治性胰腺癌患者: I期剂量递增和扩展研究

2022-10-1349
OA
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
2022-02-076
OAAI
A phase 1 pharmacokinetic trial of single agent trametinib a MEK inhibitor in advanced cancer patients with hepatic dysfunction: An NCI Organ Dysfunction Working Group (ODWG) study (NCI 9591)
2021-12-011
PRE
The clonal evolution of metastatic colorectal cancer
2020-06-1250
OAAI
Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer
2018-09-1422
OAAI
Neratinib in HER2 or HER3 mutant solid tumors: SUMMIT, a global, multi-histology, open-label, phase 2 basket study
2017-07-0110
PRE
Gastric Cancer, Version 3.2016
2016-10-03797
OAAI